Enhancing myocardial gene editing efficiency to cure cardiomyopathy
Advancing gene editing strategies aimed to cure heart disease into the clinic
The primary goal of REPAIR is to investigate and optimize the therapeutic effects of advanced and promising gene therapies to address the underlying genetic cause of a severe kind of heart disease, known as hypertrophic cardiomyopathy. To this end, we have brought together an interdisciplinary consortium that combines expertise in experimental models for heart disease and gene therapies with excellent knowledge of drug improvement and patient populations.
Genetic heart muscle diseases (cardiomyopathies) often affect young individuals for which there are currently few available medications. In the Netherlands, an important form of genetic heart muscle disease is linked to mutations in the Myosin Binding Protein C3 (MYBPC3) gene. MYBPC3 mutations lead to hypertrophic cardiomyopathy, characterized by excessive muscle growth of the heart chamber and an increased risk of sudden death as a result. Current treatment focuses mainly on palliative care, with implantable defibrillators or heart transplants being seen as a last resort. However, recent advances in gene therapy now allow us to eliminate the underlying cause of genetic diseases by correcting the disease driving mutation. This technology could lead to the development of a curative therapy for the first time. However, to achieve a safe and effective treatment for heart disease, the activity, specificity and delivery to the heart of this approach still need to be improved.
If successful, we will develop this technology as a new, innovative therapy for carriers of this disease-driving mutation. With this, REPAIR may have a major impact on the quality of life for this patient population, but also provides hope and insights for the development of gene therapies for other genetic diseases.
Andere projecten
In elk PPS-project werken kennisinstellingen, bedrijven en zorgpartijen samen aan een concrete gezondheidsvraag. Bekijk het volledige projectoverzicht.
Bekijk de programma’s
Binnen onze programma’s werken bedrijven, kennisinstellingen en regionale partners samen aan innovaties die bijdragen aan betere gezondheid en zorg.
Bekijk de partnerschappen
Strategische publiek-private partnerschappen (PPP's) zijn meerjarige samenwerkingen tussen bedrijven, kennisinstellingen en andere partijen.
Hoe kunnen we je helpen?
Heb je een vraag of wil je meer weten over Health Holland? We brengen je graag in contact met de juiste mensen, kennis en mogelijkheden om gezondheidsinnovatie te versnellen.
We hebben uw bericht ontvangen
We nemen binnen 3 tot 4 werkdagen contact met je op. Is je vraag dringend? Neem dan gerust direct contact met ons op. Hieronder zie je de contactoptie die het beste past bij je onderwerp.
Opnieuw beginnen
Er ging iets mis bij het versturen van het formulier. Probeer het opnieuw.